Hunter Medical Research Institute has formed a memorandum of understanding with Novartis (Aust & NZ) to explore future research projects focused on improving cardiovascular health. The partnership aims to accelerate innovation and enhance patient care through collaborative research initiatives.
A Newcastle research team has investigated the genetics of circulating vitamin A and its role in psychiatric disorders. The study found that genetic variation influences retinol levels, which are linked to various complex health conditions such as inflammation, vision, and brain structure connectivity.
Researchers have discovered a way to predict which individuals will respond to blood pressure treatments that lower sodium in the body. This breakthrough could lead to a 25% reduction in hypertension prevalence, resulting in significant cost savings for the Australian government.
Researchers have identified a protein that can predict how well breast cancer patients will respond to chemotherapy. Increasing levels of this variant p53 makes breast cancer cells unresponsive to existing therapies, highlighting its potential as a target for enhanced treatments.
A phase II study found that treating late-stage, treatment-resistant melanoma patients with a combination of Azacitidine and Carboplatin significantly increases their survival times. The treatment re-sensitized cancer cells to immunotherapy, allowing the body's immune system to fight the cancer.
A new video tool aims to help mothers understand that stillbirth is not their fault by explaining the aging process of the placenta. The research identifies that unexplained stillbirth is often due to 'aging of the placenta,' which is complex and not affected by the mother's behavior.
Researchers discovered a distinct difference in gene expression in women who underwent preterm labor compared to those at full term. The findings suggest new directions for studying preterm labor and potentially effective treatments.
Research into INNA-X shows it is effective against rhinovirus, the main cause of the common cold, reducing viral load and inflammation. The nasal spray works by stimulating the innate immune system, making it harder for viruses to take hold.